Live Breaking News & Updates on Agios Pharmaceuticals Stock Performance

Stay updated with breaking news from Agios pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Swiss National Bank Has $2.45 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Swiss National Bank Has $2.45 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , James William Burns , Brian Goff , Cantor Fitzgerald , Agios Pharmaceuticals Stock Performance , Exchange Commission , Swiss National Bank , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , Quarter For Agios Pharmaceuticals , China Universal Asset Management Co , News Ratings For Agios Pharmaceuticals Daily , Goldman Sachs Group , Jpmorgan Chase Co , Royal Bank , Headlands Technologies , Securities Exchange Commission , Free Report , National Bank , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Teacher Retirement System , Retirement System , Get Free Report , Visit Holdingschannel ,

The Goldman Sachs Group Boosts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00

The Goldman Sachs Group Boosts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , James William Burns , Jacqualyna Fouse , Jpmorgan Chase Co , News Ratings For Agios Pharmaceuticals Daily , Agios Pharmaceuticals , China Universal Asset Management Co , Charles Schwab Investment Management Inc , Deutsche Bank , Royal Bank , Mirae Asset Global Investments Co , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals Inc , Cantor Fitzgerald , Insider Activity At Agios Pharmaceuticals , Goldman Sachs Group , Free Report , Get Free Report , Director Jacqualyn , Schwab Investment Management , Universal Asset Management , Asset Global Investments , Agios Pharmaceuticals Daily ,

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.45) EPS for the quarter, topping analysts’ consensus estimates of ($1.64) by $0.19, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 38.08% and a negative net margin of 1,312.64%. The company had revenue of […] ....

United States , Brian Goff , James William Burns , Agios Pharmaceuticals , Agios Pharmaceuticals Inc , Royal Bank , Earnings History For Agios Pharmaceuticals , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals Company Profile , Insider Activity At Agios Pharmaceuticals , Goldman Sachs Group , Cantor Fitzgerald , News Ratings For Agios Pharmaceuticals Daily , Jpmorgan Chase Co , Get Free Report , Agios Pharmaceuticals Daily , Nasdaq Agio ,

The Goldman Sachs Group Increases Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00

Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price raised by The Goldman Sachs Group from $29.00 to $33.00 in a report issued on Friday morning, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on AGIO. JPMorgan Chase & Co. reduced […] ....

United States , Jacqualyna Fouse , Zurcher Kantonalbank Zurich Cantonalbank , James William Burns , Securities Exchange Commission , Mirae Asset Global Investments Co , Hedge Funds Weigh In On Agios Pharmaceuticals , News Ratings For Agios Pharmaceuticals Daily , Royal Bank , Goldman Sachs Group , Cantor Fitzgerald , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals , Jpmorgan Chase Co , China Universal Asset Management Co , Agios Pharmaceuticals Inc , Free Report , Get Free Report , Director Jacqualyn , Exchange Commission , Asset Global Investments , Universal Asset Management , Retirement System , Kantonalbank Zurich Cantonalbank , Rhumbline Advisers , Agios Pharmaceuticals Daily ,

The Goldman Sachs Group Increases Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target hoisted by equities researchers at The Goldman Sachs Group from $29.00 to $33.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential downside of […] ....

United States , James William Burns , Brian Goff , Goldman Sachs Group , Agios Pharmaceuticals Inc , Agios Pharmaceuticals Stock Performance , Mirae Asset Global Investments Co , Securities Exchange Commission , Oak Ridge Investments , Cantor Fitzgerald , Royal Bank , China Universal Asset Management Co , News Ratings For Agios Pharmaceuticals Daily , Jpmorgan Chase Co , Agios Pharmaceuticals , Institutional Trading Of Agios Pharmaceuticals , Get Free Report , Exchange Commission , Investment Management , Bridge Investments , Asset Global Investments , Universal Asset Management , Agios Pharmaceuticals Daily , Nasdaq Agio , Boost Price Target , The Goldman Sachs Group Inc ,